GSK's Witty talks up U.K.'s R&D future; Exelixis gets priority review for cabo; AL biotech moves to MD;

Conversations on  Twitter :

 @FierceBiotech: Models shed light on cocaine-curbing enzymes. More | Follow @FierceBiotech

 @JohnCFierce: Wall Street oddsmakers betting heavily against Lilly's solanezumab. News | Follow @JohnCFierce

 @RyanMFierce: Illumina is poised to grab more bioinformatics dollars with its cloud computing product, eventual app store. Release | Follow @RyanMFierce

> GSK ($GSK) chief Andrew Witty is a big U.K. booster. And he's been talking up some new pluses for the biopharma industry, including a lower tax rate on IP-generated profits. Witty, though, also believes that the country needs more venture funds in order for the industry to compete with some up-and-coming European countries. Story

> The FDA has provided priority review status for Exelixis's ($EXEL) cabozantinib for thyroid cancer. Story

> University of Alabama spinout Vaxin has moved to Maryland, joining a cluster of vaccine developers near Washington, D.C. Story

Pharma News

 @FiercePharma: Endocyte poaches Novartis exec David Meek to be its chief commercial officer. Report | Follow @FiercePharma

> Shire CEO sees consumer-goods strategies in pharma's future. More

> Pay-for-delay deals could be upended by the Supreme Court. Article

Medical Device News

@FierceMedDev: Another day, another Covidien 510(k) clearance, this time for a new bedside monitoring system. Report | Follow @FierceMedDev

 @MarkHFierce: Four years of working with FDA pays off. Proteus gained clearance for a new ingestible sensor. Release | Follow @MarkHFierce

 @DamianFierce: A new pig-flesh-based implant could make certain knee surgeries more successful. More | Follow @DamianFierce

> Roper buys Dx firm Sunquest for $1.4B. News

> Devicemaker Kai Medical to merge with biotech Novogen. More

> Covidien rolls out updated patient monitoring system in U.S. Story

Biotech IT News

> AZ's R&D information chief eyes improved trial success. Story

> Models shed light on cocaine-curbing enzymes. More

> Illumina seeks cut of bioinformatics biz with cloud system. Article

> AstraZeneca taps Amazon-like service for outsourcing research. News

> Complete Genomics, Ingenuity combine forces to understand genomes. Report

CRO News

> Beta Pharma to manufacture Sunshine's targeted cancer drug. Story

> Quintiles inks deal to promote COPD drug in U.K. Article

> Analysts: CMO market will double by 2018. News

> 438 died in Indian clinical trials last year. Report

> Covance takes a $12.7M loss in Q2. News

And Finally… Investigators say that curcurmin, an ingredient in curry spice which acts as an anti-inflammatory compound, can help prevent diabetes. Story

Suggested Articles

Former Ipsen and Novartis exec Harout Semerjian has been tapped as the latest chief executive of troubled Immunomedics.

A COVID-19 vaccine developed by a Mass General spinoff is among the candidates emerging from partnerships between tech developers and bio researchers.

Vir and GlaxoSmithKline will pool their resources to develop vaccines and treatments for coronaviruses, starting with two antibodies against COVID-19.